title: Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
abstract: BACKGROUND
  There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients.
  
  
  METHODS
  An international, randomized, double-masked, placebo-controlled trial (MEDENOX) has previously been conducted in 1102 acutely ill, immobilized general medical patients and has shown the efficacy of using a low-molecular-weight heparin, enoxaparin sodium, in preventing thrombosis. We performed logistic regression analysis to evaluate the independent nature of different types of acute medical illness (heart failure, respiratory failure, infection, rheumatic disorder, and inflammatory bowel disease) and predefined factors (chronic heart and respiratory failure, age, previous VTE, and cancer) as risk factors for VTE.
  
  
  RESULTS
  The primary univariate analysis showed that the presence of an acute infectious disease, age older than 75 years, cancer, and a history of VTE were statistically significantly associated with an increased VTE risk. Multiple logistic regression analysis indicated that these factors were independently associated with VTE.
  
  
  CONCLUSIONS
  Several independent risk factors for VTE were identified. These findings allow recognition of individuals at increased risk of VTE and will contribute to the formulation of an evidence-based risk assessment model for thromboprophylaxis in hospitalized general medical patients.
authors.affiliation: Academic Department of Surgery, Guy's, King's, and St Thomas' School of Medicine, London, England.
authors.forename: Raza
authors.initials: R
authors.lastname: Alikhan
authors.forename: Alexander T
authors.initials: AT
authors.lastname: Cohen
authors.forename: Sophie
authors.initials: S
authors.lastname: Combe
authors.forename: Meyer M
authors.initials: MM
authors.lastname: Samama
authors.forename: Louis
authors.initials: L
authors.lastname: Desjardins
authors.forename: Amiram
authors.initials: A
authors.lastname: Eldor
authors.forename: Charles
authors.initials: C
authors.lastname: Janbon
authors.forename: Alain
authors.initials: A
authors.lastname: Leizorovicz
authors.forename: Carl-Gustav
authors.initials: CG
authors.lastname: Olsson
authors.forename: Alexander G G
authors.initials: AG
authors.lastname: Turpie
mesh_terms: D000208:Acute Disease; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D015897:Comorbidity; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D016015:Logistic Models; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012131:Respiratory Insufficiency / Q000453:epidemiology; D012307:Risk Factors; D013923:Thromboembolism / Q000453:epidemiology* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin